Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma

Chia Hung Yen, Yao Cheng Lu, Chung Hsien Li, Cheng Ming Lee, Chia Yen Chen, Ming Yuan Cheng, Shiu Feng Huang, Kuen Feng Chen, Ann Lii Cheng, Li Ying Liao, Yan Hwa Wu Lee, Yi Ming Arthur Chen

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Glycine N-methyltransferase (GNMT) is a tumor suppressor for hepatocellular carcinoma (HCC). High rates of Gnmtknockout mice developed HCC. Epigenetic alteration and dysregulation of several pathways including wingless-type MMTV integration site (Wnt), mitogen activated protein kinase (MAPK) and Janus kinase and signal transducer and activator of transcription (JAK-STAT) are associated with HCC development in Gnmtknockout mice. We hypothesized that GNMT may regulate signal transduction through interacting with other proteins directly. In this report, we identified a mammalian target of rapamycin (mTOR) inhibitor (DEP domain containing MTOR-interacting protein [DEPDC6/DEPTOR]) as a GNMT-binding protein by using yeast two-hybrid screening. Fluorescence resonance energy transfer assay demonstrated that the C-terminal half of GNMT interact with the PSD-95/Dlg1/ZO-1 (PDZ) domain of DEPDC6/DEPTOR. Immuno histo chemical staining showed that 27.5% (14/51) of HCC patients had higher expression levels of DEPDC6/DEPTOR in the tumorous tissues than in tumor-adjacent tissues, especially among HCC patients with hepatitis B viral infection (odds ratio 10.3, 95% confidence interval [CI] 1.05-11.3) or patients with poor prognosis (death hazard ratio 4.51, 95% CI 1.60-12.7). In terms of molecular mechanism, knockdown of DEPDC6/DEPTOR expression in HuH-7 cells caused S6K and 4E-BP activation, but suppressed Akt. Over expression of DEPDC6/DEPTOR activated Akt and increased survival of HCC cells. Over expression of GNMT caused activation of mTOR/raptor downstream signaling and delayed G2/M cell cycle progression, which altogether resulted in cellular senescence. Furthermore, GNMT reduced proliferation of HuH-7 cells and sensitized them to rapamycin treatment both in vitro and in vivo. In conclusion, GNMT regulates HCC growth in part through interacting with DEPDC6/DEPTOR and modulating mTOR/raptor signaling pathway. Both GNMT and DEPDC6/DEPTOR are potential targets for developing therapeutics for HCC.

Original languageEnglish
Pages (from-to)286-296
Number of pages11
JournalMolecular Medicine
Volume18
Issue number2
DOIs
Publication statusPublished - Feb 1 2012
Externally publishedYes

Fingerprint

Glycine N-Methyltransferase
Hepatocellular Carcinoma
Sirolimus
Proteins
Raptors
Confidence Intervals
Janus Kinases
Fluorescence Resonance Energy Transfer
Cell Aging
Mitogen-Activated Protein Kinase Kinases
Virus Diseases
Hepatitis B
Transducers
Epigenomics
Signal Transduction
Neoplasms
Cell Cycle
Carrier Proteins
Yeasts
Odds Ratio

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma. / Yen, Chia Hung; Lu, Yao Cheng; Li, Chung Hsien; Lee, Cheng Ming; Chen, Chia Yen; Cheng, Ming Yuan; Huang, Shiu Feng; Chen, Kuen Feng; Cheng, Ann Lii; Liao, Li Ying; Lee, Yan Hwa Wu; Chen, Yi Ming Arthur.

In: Molecular Medicine, Vol. 18, No. 2, 01.02.2012, p. 286-296.

Research output: Contribution to journalArticle

Yen, CH, Lu, YC, Li, CH, Lee, CM, Chen, CY, Cheng, MY, Huang, SF, Chen, KF, Cheng, AL, Liao, LY, Lee, YHW & Chen, YMA 2012, 'Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma', Molecular Medicine, vol. 18, no. 2, pp. 286-296. https://doi.org/10.2119/molmed.2011.00331
Yen, Chia Hung ; Lu, Yao Cheng ; Li, Chung Hsien ; Lee, Cheng Ming ; Chen, Chia Yen ; Cheng, Ming Yuan ; Huang, Shiu Feng ; Chen, Kuen Feng ; Cheng, Ann Lii ; Liao, Li Ying ; Lee, Yan Hwa Wu ; Chen, Yi Ming Arthur. / Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma. In: Molecular Medicine. 2012 ; Vol. 18, No. 2. pp. 286-296.
@article{adab86f024fd4ef8a4933ab02b143a59,
title = "Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma",
abstract = "Glycine N-methyltransferase (GNMT) is a tumor suppressor for hepatocellular carcinoma (HCC). High rates of Gnmtknockout mice developed HCC. Epigenetic alteration and dysregulation of several pathways including wingless-type MMTV integration site (Wnt), mitogen activated protein kinase (MAPK) and Janus kinase and signal transducer and activator of transcription (JAK-STAT) are associated with HCC development in Gnmtknockout mice. We hypothesized that GNMT may regulate signal transduction through interacting with other proteins directly. In this report, we identified a mammalian target of rapamycin (mTOR) inhibitor (DEP domain containing MTOR-interacting protein [DEPDC6/DEPTOR]) as a GNMT-binding protein by using yeast two-hybrid screening. Fluorescence resonance energy transfer assay demonstrated that the C-terminal half of GNMT interact with the PSD-95/Dlg1/ZO-1 (PDZ) domain of DEPDC6/DEPTOR. Immuno histo chemical staining showed that 27.5{\%} (14/51) of HCC patients had higher expression levels of DEPDC6/DEPTOR in the tumorous tissues than in tumor-adjacent tissues, especially among HCC patients with hepatitis B viral infection (odds ratio 10.3, 95{\%} confidence interval [CI] 1.05-11.3) or patients with poor prognosis (death hazard ratio 4.51, 95{\%} CI 1.60-12.7). In terms of molecular mechanism, knockdown of DEPDC6/DEPTOR expression in HuH-7 cells caused S6K and 4E-BP activation, but suppressed Akt. Over expression of DEPDC6/DEPTOR activated Akt and increased survival of HCC cells. Over expression of GNMT caused activation of mTOR/raptor downstream signaling and delayed G2/M cell cycle progression, which altogether resulted in cellular senescence. Furthermore, GNMT reduced proliferation of HuH-7 cells and sensitized them to rapamycin treatment both in vitro and in vivo. In conclusion, GNMT regulates HCC growth in part through interacting with DEPDC6/DEPTOR and modulating mTOR/raptor signaling pathway. Both GNMT and DEPDC6/DEPTOR are potential targets for developing therapeutics for HCC.",
author = "Yen, {Chia Hung} and Lu, {Yao Cheng} and Li, {Chung Hsien} and Lee, {Cheng Ming} and Chen, {Chia Yen} and Cheng, {Ming Yuan} and Huang, {Shiu Feng} and Chen, {Kuen Feng} and Cheng, {Ann Lii} and Liao, {Li Ying} and Lee, {Yan Hwa Wu} and Chen, {Yi Ming Arthur}",
year = "2012",
month = "2",
day = "1",
doi = "10.2119/molmed.2011.00331",
language = "English",
volume = "18",
pages = "286--296",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",
number = "2",

}

TY - JOUR

T1 - Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma

AU - Yen, Chia Hung

AU - Lu, Yao Cheng

AU - Li, Chung Hsien

AU - Lee, Cheng Ming

AU - Chen, Chia Yen

AU - Cheng, Ming Yuan

AU - Huang, Shiu Feng

AU - Chen, Kuen Feng

AU - Cheng, Ann Lii

AU - Liao, Li Ying

AU - Lee, Yan Hwa Wu

AU - Chen, Yi Ming Arthur

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Glycine N-methyltransferase (GNMT) is a tumor suppressor for hepatocellular carcinoma (HCC). High rates of Gnmtknockout mice developed HCC. Epigenetic alteration and dysregulation of several pathways including wingless-type MMTV integration site (Wnt), mitogen activated protein kinase (MAPK) and Janus kinase and signal transducer and activator of transcription (JAK-STAT) are associated with HCC development in Gnmtknockout mice. We hypothesized that GNMT may regulate signal transduction through interacting with other proteins directly. In this report, we identified a mammalian target of rapamycin (mTOR) inhibitor (DEP domain containing MTOR-interacting protein [DEPDC6/DEPTOR]) as a GNMT-binding protein by using yeast two-hybrid screening. Fluorescence resonance energy transfer assay demonstrated that the C-terminal half of GNMT interact with the PSD-95/Dlg1/ZO-1 (PDZ) domain of DEPDC6/DEPTOR. Immuno histo chemical staining showed that 27.5% (14/51) of HCC patients had higher expression levels of DEPDC6/DEPTOR in the tumorous tissues than in tumor-adjacent tissues, especially among HCC patients with hepatitis B viral infection (odds ratio 10.3, 95% confidence interval [CI] 1.05-11.3) or patients with poor prognosis (death hazard ratio 4.51, 95% CI 1.60-12.7). In terms of molecular mechanism, knockdown of DEPDC6/DEPTOR expression in HuH-7 cells caused S6K and 4E-BP activation, but suppressed Akt. Over expression of DEPDC6/DEPTOR activated Akt and increased survival of HCC cells. Over expression of GNMT caused activation of mTOR/raptor downstream signaling and delayed G2/M cell cycle progression, which altogether resulted in cellular senescence. Furthermore, GNMT reduced proliferation of HuH-7 cells and sensitized them to rapamycin treatment both in vitro and in vivo. In conclusion, GNMT regulates HCC growth in part through interacting with DEPDC6/DEPTOR and modulating mTOR/raptor signaling pathway. Both GNMT and DEPDC6/DEPTOR are potential targets for developing therapeutics for HCC.

AB - Glycine N-methyltransferase (GNMT) is a tumor suppressor for hepatocellular carcinoma (HCC). High rates of Gnmtknockout mice developed HCC. Epigenetic alteration and dysregulation of several pathways including wingless-type MMTV integration site (Wnt), mitogen activated protein kinase (MAPK) and Janus kinase and signal transducer and activator of transcription (JAK-STAT) are associated with HCC development in Gnmtknockout mice. We hypothesized that GNMT may regulate signal transduction through interacting with other proteins directly. In this report, we identified a mammalian target of rapamycin (mTOR) inhibitor (DEP domain containing MTOR-interacting protein [DEPDC6/DEPTOR]) as a GNMT-binding protein by using yeast two-hybrid screening. Fluorescence resonance energy transfer assay demonstrated that the C-terminal half of GNMT interact with the PSD-95/Dlg1/ZO-1 (PDZ) domain of DEPDC6/DEPTOR. Immuno histo chemical staining showed that 27.5% (14/51) of HCC patients had higher expression levels of DEPDC6/DEPTOR in the tumorous tissues than in tumor-adjacent tissues, especially among HCC patients with hepatitis B viral infection (odds ratio 10.3, 95% confidence interval [CI] 1.05-11.3) or patients with poor prognosis (death hazard ratio 4.51, 95% CI 1.60-12.7). In terms of molecular mechanism, knockdown of DEPDC6/DEPTOR expression in HuH-7 cells caused S6K and 4E-BP activation, but suppressed Akt. Over expression of DEPDC6/DEPTOR activated Akt and increased survival of HCC cells. Over expression of GNMT caused activation of mTOR/raptor downstream signaling and delayed G2/M cell cycle progression, which altogether resulted in cellular senescence. Furthermore, GNMT reduced proliferation of HuH-7 cells and sensitized them to rapamycin treatment both in vitro and in vivo. In conclusion, GNMT regulates HCC growth in part through interacting with DEPDC6/DEPTOR and modulating mTOR/raptor signaling pathway. Both GNMT and DEPDC6/DEPTOR are potential targets for developing therapeutics for HCC.

UR - http://www.scopus.com/inward/record.url?scp=84860855581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860855581&partnerID=8YFLogxK

U2 - 10.2119/molmed.2011.00331

DO - 10.2119/molmed.2011.00331

M3 - Article

C2 - 22160218

AN - SCOPUS:84860855581

VL - 18

SP - 286

EP - 296

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

IS - 2

ER -